Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [26]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-801-014-C050 - Provider product page
- Provider
- Enzo Life Sciences
- Product name
- MVP/LRP (human) monoclonal antibody (LMR5)
- Antibody type
- Monoclonal
- Antigen
- Purified from natural sources
- Reactivity
- Human
- Host
- Rat
- Isotype
- IgG
- Antibody clone number
- LMR5
- Vial size
- 50 μg
- Storage
- -20°C
Submitted references Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.
Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas.
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia.
Multidrug resistance related proteins in primary cutaneous lymphomas.
Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Expression of the lung resistance protein (LRP) in primary breast cancer.
Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.
Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma.
Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival.
Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies.
Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.
The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.
The drug resistance-related protein LRP is the human major vault protein.
Membrane transport proteins associated with drug resistance expressed in human melanoma.
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
Schroeijers AB, Scheffer GL, Reurs AW, Pijnenborg AC, Abbondanza C, Wiemer EA, Scheper RJ
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2001 Nov;49(11):1379-85
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2001 Nov;49(11):1379-85
Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas.
Mayr D, Pannekamp U, Baretton GB, Gropp M, Meier W, Flens MJ, Scheper R, Diebold J
Pathology, research and practice 2000;196(7):469-75
Pathology, research and practice 2000;196(7):469-75
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Filipits M, Jaeger U, Simonitsch I, Chizzali-Bonfadin C, Heinzl H, Pirker R
Clinical cancer research : an official journal of the American Association for Cancer Research 2000 Sep;6(9):3417-23
Clinical cancer research : an official journal of the American Association for Cancer Research 2000 Sep;6(9):3417-23
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Chen GK, Durán GE, Mangili A, Beketic-Oreskovic L, Sikic BI
British journal of cancer 2000 Oct;83(7):892-8
British journal of cancer 2000 Oct;83(7):892-8
Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
Kusakabe H, Iwasaki H, Sano K, Kiyokane K
Archives of dermatological research 2000 Jun;292(6):292-300
Archives of dermatological research 2000 Jun;292(6):292-300
Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M, Turzanski J, Langabeer S, Russell NH
Advances in experimental medicine and biology 1999;457:77-88
Advances in experimental medicine and biology 1999;457:77-88
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia.
Pirker R, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Filipits M
Advances in experimental medicine and biology 1999;457:133-9
Advances in experimental medicine and biology 1999;457:133-9
Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW, Flens MJ, Scheper RJ, van der Valk P, Scheffer GL, Toonstra J, van Vloten WA
Advances in experimental medicine and biology 1999;457:119-31
Advances in experimental medicine and biology 1999;457:119-31
Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
Filipits M, Drach J, Pohl G, Schuster J, Stranzl T, Ackermann J, Königsberg R, Kaufmann H, Gisslinger H, Huber H, Ludwig H, Pirker R
Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Sep;5(9):2426-30
Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Sep;5(9):2426-30
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Arts HJ, Katsaros D, de Vries EG, Massobrio M, Genta F, Danese S, Arisio R, Scheper RJ, Kool M, Scheffer GL, Willemse PH, van der Zee AG, Suurmeijer AJ
Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Oct;5(10):2798-805
Clinical cancer research : an official journal of the American Association for Cancer Research 1999 Oct;5(10):2798-805
Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V, Stötzer O, Gullis E, Pelka-Fleischer R, Pogrebniak A, Gieseler F, Wilmanns W
Leukemia 1999 Nov;13(11):1864-72
Leukemia 1999 Nov;13(11):1864-72
Expression of the lung resistance protein (LRP) in primary breast cancer.
Pohl G, Filipits M, Suchomel RW, Stranzl T, Depisch D, Pirker R
Anticancer research 1999 Nov-Dec;19(6B):5051-5
Anticancer research 1999 Nov-Dec;19(6B):5051-5
Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.
Meijer GA, Schroeijers AB, Flens MJ, Meuwissen SG, van der Valk P, Baak JP, Scheper RJ
Journal of clinical pathology 1999 Jun;52(6):450-4
Journal of clinical pathology 1999 Jun;52(6):450-4
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ
Blood 1998 Mar 15;91(6):2092-8
Blood 1998 Mar 15;91(6):2092-8
Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.
Schroeijers AB, Scheffer GL, Flens MJ, Meijer GA, Izquierdo MA, van der Valk P, Scheper RJ
The American journal of pathology 1998 Feb;152(2):373-8
The American journal of pathology 1998 Feb;152(2):373-8
Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma.
Raaijmakers HG, Izquierdo MA, Lokhorst HM, de Leeuw C, Belien JA, Bloem AC, Dekker AW, Scheper RJ, Sonneveld P
Blood 1998 Feb 1;91(3):1029-36
Blood 1998 Feb 1;91(3):1029-36
Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival.
Borg AG, Burgess R, Green LM, Scheper RJ, Yin JA
British journal of haematology 1998 Dec;103(4):1083-91
British journal of haematology 1998 Dec;103(4):1083-91
Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies.
Flens MJ, Scheffer GL, van der Valk P, Broxterman HJ, Eijdems EW, Huysmans AC, Izquierdo MA, Scheper RJ
International journal of cancer 1997 Oct 9;73(2):249-57
International journal of cancer 1997 Oct 9;73(2):249-57
Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Stein U, Walther W, Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH
Journal of the National Cancer Institute 1997 Jun 4;89(11):807-13
Journal of the National Cancer Institute 1997 Jun 4;89(11):807-13
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Den Boer ML, Zwaan CM, Pieters R, Kazemier KM, Rottier MM, Flens MJ, Scheper RJ, Veerman AJ
Leukemia 1997 Jul;11(7):1078-85
Leukemia 1997 Jul;11(7):1078-85
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.
Izquierdo MA, Scheffer GL, Flens MJ, Giaccone G, Broxterman HJ, Meijer CJ, van der Valk P, Scheper RJ
The American journal of pathology 1996 Mar;148(3):877-87
The American journal of pathology 1996 Mar;148(3):877-87
Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.
List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, Wolff SN, Broxterman HJ, Scheffer GL, Scheper RJ, Dalton WS
Blood 1996 Mar 15;87(6):2464-9
Blood 1996 Mar 15;87(6):2464-9
The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.
Slovak ML, Ho JP, Cole SP, Deeley RG, Greenberger L, de Vries EG, Broxterman HJ, Scheffer GL, Scheper RJ
Cancer research 1995 Oct 1;55(19):4214-9
Cancer research 1995 Oct 1;55(19):4214-9
The drug resistance-related protein LRP is the human major vault protein.
Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC, Scheper RJ
Nature medicine 1995 Jun;1(6):578-82
Nature medicine 1995 Jun;1(6):578-82
Membrane transport proteins associated with drug resistance expressed in human melanoma.
Schadendorf D, Makki A, Stahr C, van Dyck A, Wanner R, Scheffer GL, Flens MJ, Scheper R, Henz BM
The American journal of pathology 1995 Dec;147(6):1545-52
The American journal of pathology 1995 Dec;147(6):1545-52
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG, van der Valk P
Cancer research 1993 Apr 1;53(7):1475-9
Cancer research 1993 Apr 1;53(7):1475-9
No comments: Submit comment
No validations: Submit validation data